Automation technology suppliers are integrating robot kinematics directly into PLCs, simplifying programming, reducing costs, ...
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback